Data as of Sep 29, 2026 · Based on 521 AI responses · See how Parse measures this
Certara provides software and services that support drug development from discovery through market, integrating modeling, analytics, and regulatory expertise to accelerate decision-making. Its offerings include model-informed drug development, biosimulation, and PBPK, as well as regulatory strategy, data standardization, and submission tools across preclinical to market stages. By combining AI-driven tools with specialized platforms (e.g., Simcyp, Phoenix, Pinnacle 21, GlobalSubmit) and tailored consulting, Certara helps optimize dosing, safety, trial design, and market access.
<1%No change
of AI answers about Certara ToxStudio and its rivals. Week of Sep 21
“Certara ToxStudio: An integrated suite utilizing AI-powered QSAR and Bayesian predictive models to flag safety hazards”
“Certara ToxStudio / Libra : Integrates leading quantitative structure-activity relationship (QSAR) and AI-driven modeling to assess critical preclinical endpoints”
AI mentioned Certara ToxStudio in <1% of answers about Certara ToxStudio and its rivals in the week of Sep 21.
Certara ToxStudio is a product of Certara.
Excerpts where Certara ToxStudio appeared in the AI's answer
Certara ToxStudio: An integrated suite utilizing AI-powered QSAR and Bayesian predictive models to flag safety hazards
Certara ToxStudio / Libra : Integrates leading quantitative structure-activity relationship (QSAR) and AI-driven modeling to assess critical preclinical endpoints
